1
PDL Biopharma
Leadership team
Cary Queen (Founder)
Laurence J. Korn (Founder)
Products/ Services
Biotechnology, Health Care, Medical
Number of Employees
100 - 500
Headquarters
Incline Village, Nevada, United States
Established
1986
Company Registration
SEC CIK number: 0000882104
Traded as
NASDAQ:PDLI
URL
Overview
Location
Summary
PDL BioPharma, Inc., (NASDAQ: PDLI) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics to enhance the lives of patients stricken by disease. We focus on turning innovative science into important new therapies to improve patient outcomes.
History
PDL BioPharma was founded in 1986 and has since grown to become a leader in the development and commercialization of innovative therapeutics that improve patient outcomes. PDL has a long track record of pioneering first-in-class and best-in-class treatments that have helped patients across the world. PDL’s R&D platform has encompassed small molecules and biologics, including antibodies and Fc fusion proteins.
Mission
To empower and enable healthier lives through the development of innovative and differentiated products and services in collaborative partnerships with our customer.
Vision
To be a leader in biopharmaceuticals and deliver the most advanced therapeutic solutions to enhance the lives of patients.
Key Team
Cary Queen (Founder)
Laurence J. Korn (Founder)
Recognition and Awards
PDL has earned numerous awards and distinctions in recognition of its achievements in advancing patient care, including being named one of Forbes’ Most Innovative Companies in 2016 and one of Deloitte’s Fast 500 award recipients in 2017.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Cary Queen (Founder)
Laurence J. Korn (Founder)
Products/ Services
Biotechnology, Health Care, Medical
Number of Employees
100 - 500
Headquarters
Incline Village, Nevada, United States
Established
1986
Company Registration
SEC CIK number: 0000882104
Traded as
NASDAQ:PDLI
URL